Cargando…

An Open Pilot Study of the Effect and Tolerability of Add-On Multivitamin Therapy in Patients with Intractable Focal Epilepsy

Observational studies have investigated the potential modulatory effect of neuronal excitability by vitamins in epilepsy. We aimed to investigate whether the addition of multivitamin therapy (B6/B9, D, E and Q) to regular antiepileptic drug therapy could ameliorate seizures in patients with refracto...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Hui Hua, Sung, Pi-Shan, Liao, Wei Chen, Chang, Alice Y. W., Hsiao, Ya-Hsin, Fu, Tzu-Fun, Huang, Chin-Ying, Huang, Chin-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468939/
https://www.ncbi.nlm.nih.gov/pubmed/32784611
http://dx.doi.org/10.3390/nu12082359
_version_ 1783578319848996864
author Chang, Hui Hua
Sung, Pi-Shan
Liao, Wei Chen
Chang, Alice Y. W.
Hsiao, Ya-Hsin
Fu, Tzu-Fun
Huang, Chin-Ying
Huang, Chin-Wei
author_facet Chang, Hui Hua
Sung, Pi-Shan
Liao, Wei Chen
Chang, Alice Y. W.
Hsiao, Ya-Hsin
Fu, Tzu-Fun
Huang, Chin-Ying
Huang, Chin-Wei
author_sort Chang, Hui Hua
collection PubMed
description Observational studies have investigated the potential modulatory effect of neuronal excitability by vitamins in epilepsy. We aimed to investigate whether the addition of multivitamin therapy (B6/B9, D, E and Q) to regular antiepileptic drug therapy could ameliorate seizures in patients with refractory focal epilepsy. We conducted a prospective cohort open study to investigate the effect and tolerability of add-on multivitamin therapy (daily dose: B6 100 mg, B9 5 mg, D 1000 IU, E 400 IU and coenzyme Q10 100 mg) in patients with intractable focal epilepsy. All patients had effect and safety assessments at baseline and after one, three and six months of the supplementation. Thirty patients (11 men and 19 women) with a mean age of 42.37 ± 9.40 years were recruited and four patients discontinued. The seizure frequency significantly decreased after the six-month supplementation (9.04 ± 18.16/month and 2.06 ± 3.89/month, p = 0.045). At the final visit, 62.5% of the patients showed a ≥50% reduction in seizure frequency, and 12.5% were seizure-free. As to safety and tolerability, most patients did not experience significant adverse events, although three patients reported seizure worsening. In conclusion, this pilot study demonstrated the therapeutic potential and essentially good tolerability of add-on multivitamin therapy in patients with refractory focal epilepsy.
format Online
Article
Text
id pubmed-7468939
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74689392020-09-04 An Open Pilot Study of the Effect and Tolerability of Add-On Multivitamin Therapy in Patients with Intractable Focal Epilepsy Chang, Hui Hua Sung, Pi-Shan Liao, Wei Chen Chang, Alice Y. W. Hsiao, Ya-Hsin Fu, Tzu-Fun Huang, Chin-Ying Huang, Chin-Wei Nutrients Article Observational studies have investigated the potential modulatory effect of neuronal excitability by vitamins in epilepsy. We aimed to investigate whether the addition of multivitamin therapy (B6/B9, D, E and Q) to regular antiepileptic drug therapy could ameliorate seizures in patients with refractory focal epilepsy. We conducted a prospective cohort open study to investigate the effect and tolerability of add-on multivitamin therapy (daily dose: B6 100 mg, B9 5 mg, D 1000 IU, E 400 IU and coenzyme Q10 100 mg) in patients with intractable focal epilepsy. All patients had effect and safety assessments at baseline and after one, three and six months of the supplementation. Thirty patients (11 men and 19 women) with a mean age of 42.37 ± 9.40 years were recruited and four patients discontinued. The seizure frequency significantly decreased after the six-month supplementation (9.04 ± 18.16/month and 2.06 ± 3.89/month, p = 0.045). At the final visit, 62.5% of the patients showed a ≥50% reduction in seizure frequency, and 12.5% were seizure-free. As to safety and tolerability, most patients did not experience significant adverse events, although three patients reported seizure worsening. In conclusion, this pilot study demonstrated the therapeutic potential and essentially good tolerability of add-on multivitamin therapy in patients with refractory focal epilepsy. MDPI 2020-08-07 /pmc/articles/PMC7468939/ /pubmed/32784611 http://dx.doi.org/10.3390/nu12082359 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Chang, Hui Hua
Sung, Pi-Shan
Liao, Wei Chen
Chang, Alice Y. W.
Hsiao, Ya-Hsin
Fu, Tzu-Fun
Huang, Chin-Ying
Huang, Chin-Wei
An Open Pilot Study of the Effect and Tolerability of Add-On Multivitamin Therapy in Patients with Intractable Focal Epilepsy
title An Open Pilot Study of the Effect and Tolerability of Add-On Multivitamin Therapy in Patients with Intractable Focal Epilepsy
title_full An Open Pilot Study of the Effect and Tolerability of Add-On Multivitamin Therapy in Patients with Intractable Focal Epilepsy
title_fullStr An Open Pilot Study of the Effect and Tolerability of Add-On Multivitamin Therapy in Patients with Intractable Focal Epilepsy
title_full_unstemmed An Open Pilot Study of the Effect and Tolerability of Add-On Multivitamin Therapy in Patients with Intractable Focal Epilepsy
title_short An Open Pilot Study of the Effect and Tolerability of Add-On Multivitamin Therapy in Patients with Intractable Focal Epilepsy
title_sort open pilot study of the effect and tolerability of add-on multivitamin therapy in patients with intractable focal epilepsy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468939/
https://www.ncbi.nlm.nih.gov/pubmed/32784611
http://dx.doi.org/10.3390/nu12082359
work_keys_str_mv AT changhuihua anopenpilotstudyoftheeffectandtolerabilityofaddonmultivitamintherapyinpatientswithintractablefocalepilepsy
AT sungpishan anopenpilotstudyoftheeffectandtolerabilityofaddonmultivitamintherapyinpatientswithintractablefocalepilepsy
AT liaoweichen anopenpilotstudyoftheeffectandtolerabilityofaddonmultivitamintherapyinpatientswithintractablefocalepilepsy
AT changaliceyw anopenpilotstudyoftheeffectandtolerabilityofaddonmultivitamintherapyinpatientswithintractablefocalepilepsy
AT hsiaoyahsin anopenpilotstudyoftheeffectandtolerabilityofaddonmultivitamintherapyinpatientswithintractablefocalepilepsy
AT futzufun anopenpilotstudyoftheeffectandtolerabilityofaddonmultivitamintherapyinpatientswithintractablefocalepilepsy
AT huangchinying anopenpilotstudyoftheeffectandtolerabilityofaddonmultivitamintherapyinpatientswithintractablefocalepilepsy
AT huangchinwei anopenpilotstudyoftheeffectandtolerabilityofaddonmultivitamintherapyinpatientswithintractablefocalepilepsy
AT changhuihua openpilotstudyoftheeffectandtolerabilityofaddonmultivitamintherapyinpatientswithintractablefocalepilepsy
AT sungpishan openpilotstudyoftheeffectandtolerabilityofaddonmultivitamintherapyinpatientswithintractablefocalepilepsy
AT liaoweichen openpilotstudyoftheeffectandtolerabilityofaddonmultivitamintherapyinpatientswithintractablefocalepilepsy
AT changaliceyw openpilotstudyoftheeffectandtolerabilityofaddonmultivitamintherapyinpatientswithintractablefocalepilepsy
AT hsiaoyahsin openpilotstudyoftheeffectandtolerabilityofaddonmultivitamintherapyinpatientswithintractablefocalepilepsy
AT futzufun openpilotstudyoftheeffectandtolerabilityofaddonmultivitamintherapyinpatientswithintractablefocalepilepsy
AT huangchinying openpilotstudyoftheeffectandtolerabilityofaddonmultivitamintherapyinpatientswithintractablefocalepilepsy
AT huangchinwei openpilotstudyoftheeffectandtolerabilityofaddonmultivitamintherapyinpatientswithintractablefocalepilepsy